Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
109.8 USD | -2.00% | -0.87% | -10.78% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.78% | 7.06B | |
+31.37% | 588B | |
-3.23% | 364B | |
+19.33% | 326B | |
+5.21% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.07% | 167B | |
-0.02% | 161B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Baird Initiates Jazz Pharmaceuticals With Outperform Rating, Price Target is $160